Safety of hot water extract of fruits and peduncles of Hovenia dulcis as a novel food pursuant to Regulation 1(EU) 2015/2283

Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of ‘Hovenia dulcis fruit extract’ as a novel food (NF) for its use in food supplements. The NF concerns a hot water extract of sliced and dried fruits and peduncles of Hovenia dulcis Thun. The production process is described in sufficient detail but contains contradictory information regarding the mixing with another ingredient of the NF. The NF is comprised of mostly carbohydrates (about 90%), about 2% proteins, 5% moisture, less than 1% fat and about 2% ash. In addition, the NF contains small amounts of flavonoids such as dihydromyricetin, myricetin and quercetin. The Panel notes limitations of the data provided from the batch testing regarding proximate analyses and plant secondary metabolites. Given these limitations, the Panel considers that the data provided by the applicant do not demonstrate that different batches produced with the described production process meet the proposed specifications. The target population is the general adult population excluding pregnant and lactating women and people with a chronic disease, such as liver malfunction. Limited information was provided on a history of consumption of Hovenia dulcis fruits and on an extract approved in South Korea. A number of toxicological studies were performed. However, the study reports did not allow to verify that the test item was representative of the NF. The same applied to a human study provided by the applicant. The Panel concludes that the safety of the NF has not been established.

[1]  Juan Manuel Parra Morte,et al.  Genotoxicity assessment of chemical mixtures , 2018, EFSA journal. European Food Safety Authority.

[2]  Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents , 2018, OECD Guidelines for the Testing of Chemicals, Section 4.

[3]  Y. J. Kim,et al.  A standardized extract of the fruit of Hovenia dulcis alleviated alcohol-induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. , 2017, Journal of ethnopharmacology.

[4]  Josef Schlatter,et al.  Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 , 2016 .

[5]  H. Yoo,et al.  HPLC Determination of Bioactive Flavonoids in Hovenia dulcis Fruit Extracts. , 2015, Journal of chromatographic science.

[6]  R. Maronpot,et al.  Genotoxicity evaluation of the flavonoid, myricitrin, and its aglycone, myricetin. , 2015, Food and Chemical Toxicology.

[7]  M. Uesaka,et al.  Induction of cytotoxic and genotoxic responses by natural and novel quercetin glycosides. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[8]  T. K. Lim,et al.  Edible Medicinal And Non-Medicinal Plants , 2013, Springer Netherlands.

[9]  Jackson Roberto Eleotério,et al.  CRESCIMENTO EM DIÂMETRO, ALTURA E VOLUME DE Hovenia dulcis NA REGIÃO SUL DE BLUMENAU, SC , 2012 .

[10]  Duk Soo Kim,et al.  A Pediatric Case of Toxic Hepatitis Induced by Hovenia Dulcis , 2012 .

[11]  J. Martín-García,et al.  Sustainable Forest Management - Case Studies , 2012 .

[12]  Jackson Roberto Eleotério,et al.  Diameter, height and volume growth of Hovenia dulcis in south Blumenau, SC. , 2012 .

[13]  C. Bolognesi,et al.  Scientific opinion on genotoxicity testing strategies applicable to food and 3 feed safety assessment , 2011 .

[14]  C. Yu,et al.  Hovenia dulcis – An Asian Traditional Herb , 2010, Planta medica.

[15]  Seung-sik Hwang,et al.  Dietary supplement use by South Korean adults: Data from the national complementary and alternative medicine use survey (NCAMUS) in 2006 , 2010, Nutrition research and practice.

[16]  M. Bampi,et al.  Composição centesimal do fruto, extrato concentrado e da farinha da uva-do-japão , 2010 .

[17]  Yi Shuzhen,et al.  The nootropic components of Hovenia dulcis , 2009 .

[18]  C. Chau,et al.  The development of regulations of Chinese herbal medicines for both medicinal and food uses , 2006 .

[19]  Baojun Xu,et al.  Chemical Compositions of the Genus Hovenia , 2003 .

[20]  Kelly E Heim,et al.  Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. , 2002, The Journal of nutritional biochemistry.

[21]  R. Alam,et al.  Histamine release. , 2000, Methods in molecular biology.

[22]  L. Ding,et al.  [Study on flavonoids in seeds of Hovenia dulcis]. , 1997, Yao xue xue bao = Acta pharmaceutica Sinica.

[23]  Takaharu Tanaka,et al.  [Bioactive constituents of Chinese natural medicines. III. Absolute stereostructures of new dihydroflavonols, hovenitins I, II, and III, isolated from hoveniae semen seu fructus, the seed and fruit of Hovenia dulcis THUNB. (Rhamnaceae): inhibitory effect on alcohol-induced muscular relaxation and he , 1997, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[24]  N. Murakami,et al.  Bioactive saponins and glycosides. IV. Four methyl-migrated 16,17-seco-dammarane triterpene gylcosides from Chinese natural medicine, hoveniae semen seu fructus, the seeds and fruit of Hovenia dulcis THUNB.: absolute stereostructures and inhibitory activity on histamine release of hovenidulciosides , 1996, Chemical & pharmaceutical bulletin.

[25]  H. Shimoda,et al.  Absolute stereostructures of hovenidulciosides A1 and A2, bioactive novel triterpene glycosides from hoveniae semen seu fructus, the seeds and fruit of Hovenia dulcis Thunb. , 1995, Chemical & pharmaceutical bulletin.

[26]  F. W. Martin,et al.  Perennial edible fruits of the tropics : an inventory , 1987 .